MitoGenix Therapeutics Email Formats

About MitoGenix Therapeutics

MitoGenix Therapeutics LLC stands as a leading biotech startup, uniquely positioned to advance mitochondrial therapeutic research. Our specialized focus encompasses chronic inflammation, cancer, neurological disorders, metabolic diseases, and military health applications. We offer a comprehensive suite of direct-to-consumer genetic mitochondrial services, including pre-engineered, genetically modified mitochondria derived from human and murine cell lines, alongside disease-specific isolated mitochondria. Our core service provides a user-friendly online platform for bioinformatic and AI-directed genetic network assessment for outcome prediction. Furthermore, our advanced in vitro models are designed to facilitate extensive translational research into mitochondrial transfer and reprogramming. The foundational mission of MitoGenix Therapeutics LLC is to optimize research workflows by providing high-quality, ready-to-use biological transcriptomics, bioinformatics, and predictive machine-based tools and models. This strategic approach aims to significantly reduce research timelines and labor, enhance translational efficiency, and ultimately accelerate drug discovery, deepen mechanistic understanding of mitochondrial diseases, and enable the development of groundbreaking therapeutic strategies.

View contact profiles from MitoGenix Therapeutics